Modus Therapeutics Holding AB (OSTO:MODTX) Pretax Margin %: % (As of Mar. 2026)


OSTO:MODTX Modus Therapeutics Holding AB OSTO:MODTX
30 GF Score
Price kr0.38
! 1 Warning Sign
View Full Analysis

What is Modus Therapeutics Holding AB Pretax Margin %?

Modus Therapeutics Holding AB OSTO:MODTX +2.41% 30 Pretax Margin % is % as of Mar. 2026. GuruFocus rates OSTO:MODTX with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 944 Biotechnology companies, Modus Therapeutics Holding AB ranks worse than 105932.1% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Modus Therapeutics Holding AB's Pre-Tax Income for the three months ended in Mar. 2026 was kr-3.28 Mil. Modus Therapeutics Holding AB's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Modus Therapeutics Holding AB's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for Modus Therapeutics Holding AB's Pretax Margin % or its related term are showing as below:


OSTO:MODTX's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Modus Therapeutics Holding AB  (OSTO:MODTX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Modus Therapeutics Holding AB Pretax Margin % Related Terms


Modus Therapeutics Holding AB Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Modus Therapeutics Holding AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modus Therapeutics Holding AB Pretax Margin % Chart

Modus Therapeutics Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Modus Therapeutics Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:MODTX vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Modus Therapeutics Holding AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modus Therapeutics Holding AB Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Modus Therapeutics Holding AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Modus Therapeutics Holding AB's Pretax Margin % falls into.


OSTO:MODTX
30GF Score
Modus Therapeutics Holding AB OSTO:MODTX
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modus Therapeutics Holding AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Modus Therapeutics Holding AB's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-18.543/0
= %

Modus Therapeutics Holding AB's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.282/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Modus Therapeutics Holding AB (OSTO:MODTX) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Modus Therapeutics Holding AB and its competitors. According to the industry distribution chart, Modus Therapeutics Holding AB ranks #999999 out of 944 companies in the Biotechnology industry.
Is Modus Therapeutics Holding AB's Pretax Margin % too high?
Modus Therapeutics Holding AB's current Pretax Margin % is %. Based on the distribution chart, Modus Therapeutics Holding AB ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Modus Therapeutics Holding AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Modus Therapeutics Holding AB's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Modus Therapeutics Holding AB ranks #999999 out of 944 companies for Pretax Margin %. This places Modus Therapeutics Holding AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Modus Therapeutics Holding AB and its competitors. Modus Therapeutics Holding AB's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modus Therapeutics Holding AB stock overvalued right now?
Modus Therapeutics Holding AB (OSTO:MODTX) has a current Pretax Margin % of %. The current Pretax Margin % is %. Modus Therapeutics Holding AB's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Modus Therapeutics Holding AB (OSTO:MODTX), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modus Therapeutics Holding AB Business Description

Address Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish biotechnology company developing its patented polysaccharide, sevuparin, as a potential treatment for unmet medical needs. Its research focuses on conditions involving severe systemic inflammation, including sepsis and septic shock, severe malaria, and other related disorders, as well as anemia associated with chronic inflammatory conditions such as kidney disease.
30GF Score

Get the complete analysis for OSTO:MODTX

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.38
Price